ARENA OBESITY DRUG APPROVAL MAY SIGNAL FDA OPENING UP FAT PILL FLOODGATES
The U.S. Food and Drug Administration (FDA) has approved the first obesity drug in 15 years. The drug is lorcaserin, dubbed Belviq, from Arena Pharmaceuticals (ARNA).
The drug works by affecting the area of the brain that regulates metabolism.
The issue with weight loss drugs has not been efficacy, rather the side effects. The drug from Arena works similarly to Fen-phen. Fen-phen was banned about 15 years ago in the aftermath of serious side effects related to heart valves.
The drug will be marketed by a Japanese company,Eisai. Projections are that lorcaserin will become a $1.5 billion drug.
Jack Lief, Arena’s president said.… Please click here or the title below to read more.